Government of Quebec offers improved access to diabetes treatments

Boehringer Ingelheim Ltd. and Eli Lilly Canada Inc. announced today the Government of Quebec will continue to provide public funding of JARDIANCE® (empagliflozin), SYNJARDY® (a single-pill combination of empagliflozin and metformin), and TRAJENTA® (linag https://www.newswire.ca/news-releases/government-of-quebec-offers-improved-access-to-diabetes-treatments-701327461.html